Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-003855
Filing Date
2025-01-10
Accepted
2025-01-10 09:00:09
Documents
1
Period of Report
2025-01-08

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8710
  Complete submission text file 0000950170-25-003855.txt   10182
Mailing Address C/O INSULET CORPORATION 600 TECHNOLOGY PARK DRIVE, SUITE 200 BILLERICA MA 01821
Business Address
Dorval Allison (Reporting) CIK: 0001625110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 25520681

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)